Lourdes Mendez, Ph.D., M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alcohol Oxidoreductases | 1 | 2008 | 186 | 0.330 |
Why?
|
| Mucin-1 | 2 | 2017 | 545 | 0.240 |
Why?
|
| Weibel-Palade Bodies | 1 | 2020 | 18 | 0.220 |
Why?
|
| Thrombocythemia, Essential | 1 | 2021 | 85 | 0.220 |
Why?
|
| Polycythemia Vera | 1 | 2021 | 139 | 0.210 |
Why?
|
| Leukemia, Myeloid, Acute | 3 | 2019 | 3027 | 0.200 |
Why?
|
| Dyskeratosis Congenita | 1 | 2019 | 72 | 0.190 |
Why?
|
| Protein Disulfide-Isomerases | 1 | 2021 | 208 | 0.190 |
Why?
|
| Exocytosis | 1 | 2020 | 379 | 0.190 |
Why?
|
| RNA, Ribosomal | 1 | 2019 | 252 | 0.180 |
Why?
|
| Sterol Regulatory Element Binding Proteins | 1 | 2018 | 29 | 0.180 |
Why?
|
| Janus Kinase 2 | 1 | 2021 | 505 | 0.180 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2018 | 120 | 0.170 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 2019 | 239 | 0.170 |
Why?
|
| Protein Phosphatase 1 | 1 | 2018 | 143 | 0.170 |
Why?
|
| Azepines | 1 | 2019 | 350 | 0.170 |
Why?
|
| von Willebrand Factor | 1 | 2020 | 614 | 0.170 |
Why?
|
| Lipogenesis | 1 | 2018 | 207 | 0.160 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2019 | 443 | 0.160 |
Why?
|
| Tretinoin | 1 | 2019 | 519 | 0.150 |
Why?
|
| Repressor Proteins | 1 | 2008 | 3059 | 0.150 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2008 | 4716 | 0.140 |
Why?
|
| Stem Cell Niche | 1 | 2018 | 366 | 0.140 |
Why?
|
| Epigenomics | 1 | 2019 | 768 | 0.130 |
Why?
|
| DNA-Binding Proteins | 3 | 2010 | 9934 | 0.130 |
Why?
|
| B-Lymphocytes | 1 | 2008 | 4913 | 0.130 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2019 | 761 | 0.130 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2017 | 665 | 0.130 |
Why?
|
| Germ-Line Mutation | 1 | 2019 | 1674 | 0.110 |
Why?
|
| Enzyme Activation | 1 | 2018 | 3969 | 0.110 |
Why?
|
| Leukemia | 1 | 2018 | 1449 | 0.100 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2010 | 131 | 0.100 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 2 | 2010 | 1252 | 0.100 |
Why?
|
| MAP Kinase Signaling System | 1 | 2018 | 1617 | 0.100 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2020 | 3006 | 0.100 |
Why?
|
| Gene Expression Regulation | 2 | 2008 | 12680 | 0.100 |
Why?
|
| Neoplastic Stem Cells | 1 | 2018 | 1390 | 0.100 |
Why?
|
| Chemokine CCL3 | 1 | 2008 | 85 | 0.090 |
Why?
|
| Thrombosis | 1 | 2021 | 2759 | 0.090 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2018 | 1885 | 0.090 |
Why?
|
| Cell Proliferation | 4 | 2018 | 10990 | 0.080 |
Why?
|
| Pyrimidines | 1 | 2019 | 2909 | 0.080 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2018 | 1613 | 0.080 |
Why?
|
| Prostatic Neoplasms | 2 | 2018 | 10439 | 0.070 |
Why?
|
| RNA, Messenger | 2 | 2019 | 13469 | 0.070 |
Why?
|
| MicroRNAs | 2 | 2017 | 3587 | 0.070 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2019 | 11115 | 0.070 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2008 | 1858 | 0.070 |
Why?
|
| Cell Line, Tumor | 6 | 2018 | 17251 | 0.070 |
Why?
|
| Nuclear Proteins | 1 | 2019 | 6009 | 0.070 |
Why?
|
| Protein Interaction Mapping | 1 | 2008 | 660 | 0.060 |
Why?
|
| STAT3 Transcription Factor | 1 | 2007 | 968 | 0.060 |
Why?
|
| Limonins | 1 | 2020 | 24 | 0.060 |
Why?
|
| RNA Interference | 2 | 2008 | 3103 | 0.060 |
Why?
|
| Idarubicin | 1 | 2019 | 62 | 0.050 |
Why?
|
| Mutation | 3 | 2021 | 28848 | 0.050 |
Why?
|
| RNA, Small Nucleolar | 1 | 2019 | 31 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 4 | 2019 | 23439 | 0.050 |
Why?
|
| U937 Cells | 1 | 2019 | 282 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 2 | 2010 | 215 | 0.050 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2008 | 3983 | 0.050 |
Why?
|
| Mice, Knockout | 3 | 2019 | 15597 | 0.040 |
Why?
|
| Cytarabine | 1 | 2019 | 683 | 0.040 |
Why?
|
| RNA, Small Interfering | 1 | 2008 | 3713 | 0.040 |
Why?
|
| Endosomes | 1 | 2020 | 526 | 0.040 |
Why?
|
| Methylation | 1 | 2019 | 1126 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2017 | 298 | 0.040 |
Why?
|
| Neoplasm Metastasis | 2 | 2018 | 5391 | 0.040 |
Why?
|
| Mice | 6 | 2019 | 80803 | 0.040 |
Why?
|
| Lymphocyte Activation | 1 | 2007 | 5989 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 1 | 2008 | 6150 | 0.040 |
Why?
|
| Ribonuclease III | 1 | 2017 | 256 | 0.040 |
Why?
|
| Mice, Transgenic | 2 | 2019 | 10094 | 0.040 |
Why?
|
| Protein Binding | 1 | 2008 | 9947 | 0.030 |
Why?
|
| Leukemia, Myeloid | 1 | 2018 | 742 | 0.030 |
Why?
|
| Neoplasm Proteins | 1 | 2008 | 3972 | 0.030 |
Why?
|
| Gene Amplification | 1 | 2018 | 1094 | 0.030 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2018 | 675 | 0.030 |
Why?
|
| Neoplasms, Experimental | 1 | 2019 | 1416 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2018 | 831 | 0.030 |
Why?
|
| Immunomodulation | 1 | 2017 | 547 | 0.030 |
Why?
|
| Animals | 7 | 2019 | 170849 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2017 | 1393 | 0.030 |
Why?
|
| Macrophages | 1 | 2008 | 5748 | 0.030 |
Why?
|
| Cell Line | 1 | 2008 | 17137 | 0.030 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2018 | 1157 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2017 | 1042 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2017 | 1626 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2019 | 6835 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2017 | 1889 | 0.030 |
Why?
|
| Humans | 11 | 2021 | 686663 | 0.020 |
Why?
|
| Cell Communication | 1 | 2017 | 1658 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2018 | 2568 | 0.020 |
Why?
|
| Tyrphostins | 1 | 2007 | 79 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2018 | 2833 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2017 | 4441 | 0.020 |
Why?
|
| Acute Disease | 1 | 2018 | 7202 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2018 | 3053 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2019 | 3457 | 0.020 |
Why?
|
| Male | 6 | 2021 | 352465 | 0.020 |
Why?
|
| Molecular Chaperones | 1 | 2010 | 771 | 0.020 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2010 | 786 | 0.020 |
Why?
|
| Germinal Center | 1 | 2007 | 354 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2010 | 2913 | 0.020 |
Why?
|
| Cytokines | 1 | 2018 | 7147 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 9661 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2010 | 3881 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2018 | 20620 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 18495 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2021 | 23739 | 0.010 |
Why?
|
| Aged | 2 | 2021 | 162271 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 39737 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2021 | 49071 | 0.010 |
Why?
|
| Cell Survival | 1 | 2007 | 6288 | 0.010 |
Why?
|
| Middle Aged | 2 | 2021 | 216468 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 59331 | 0.010 |
Why?
|
| Base Sequence | 1 | 2007 | 13729 | 0.010 |
Why?
|
| Female | 3 | 2021 | 375459 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2018 | 24351 | 0.010 |
Why?
|
| Risk Factors | 1 | 2019 | 69278 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2007 | 8130 | 0.010 |
Why?
|
| Adult | 1 | 2021 | 211400 | 0.010 |
Why?
|